|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 257 studies with search of: | Tamoxifen |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
|
||||
| 2 | Active, not recruiting |
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
|
||||
| 3 | Completed |
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
|
||||
| 4 | Active, not recruiting |
Liver Safety Under Upfront Arimidex vs Tamoxifen
|
||||
| 5 | Recruiting |
Tamoxifen Citrate in Patients With Breast Cancer
|
||||
| 6 | Terminated |
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
|
||||
| 7 | Completed |
Randomized Study Comparing Tamoxifen Vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-Positive Patients
|
||||
| 8 | Completed |
Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant
|
||||
| 9 | Enrolling by invitation |
Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women
|
||||
| 10 | Recruiting |
CYP2D6 Genotype on the Clinical Effect of Tamoxifen
|
||||
| 11 | Completed |
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
|
||||
| 12 | Completed |
The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer
|
||||
| 13 | Recruiting |
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment
|
||||
| 14 | Recruiting |
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ
|
||||
| 15 | Recruiting |
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
|
||||
| 16 | Recruiting |
Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
|
||||
| 17 | Completed |
Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
|
||||
| 18 | Active, not recruiting |
ATAC - Arimidex, Tamoxifen Alone or in Combination
|
||||
| 19 | Recruiting |
Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment
|
||||
| 20 | Recruiting |
Tamoxifen Citrate Alone or Ovarian Function Suppression and Tamoxifen Citrate or Exemestane in Treating Premenopausal Women Who Have Undergone Surgery for Breast Cancer
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|